Noninvasive test for NASH, fibrosis in patients with psoriasis

Noninvasive test for NASH, fibrosis in patients with psoriasis

(HealthDay)—For patients with psoriasis receiving long-term methotrexate sodium therapy, a noninvasive test for nonalcoholic steatohepatitis (NASH) and hepatic fibrosis (NASH FibroSure) can be used to monitor development of methotrexate-induced hepatotoxic effects, with a significant correlation for cumulative methotrexate dose with higher score in women, but not men, according to research published online Aug. 23 in JAMA Dermatology.

Bruce Bauer, M.D., from Pariser Dermatology Specialists in Norfolk, Va., and colleagues conducted a retrospective descriptive analysis among with psoriasis treated with who underwent NASH FibroSure testing at a dermatology referral center. Data were included for 129 patients with psoriasis receiving methotrexate treatment, while 107 patients underwent NASH FibroSure testing during methotrexate therapy.

The researchers found that 53.5 percent of the 129 patients underwent NASH FibroSure testing before starting methotrexate; 27.5 and 78.3 percent of those had elevated fibrosis and steatosis scores, respectively. Among the 107 patients who underwent NASH FibroSure testing during methotrexate therapy, there was a significant correlation for cumulative methotrexate dose with higher NASH FibroSure score in women (P = 0.02), but not men (P = 0.11). Except for one patient, all were managed without liver biopsy.

"In a single-institution cohort, these results suggest that NASH FibroSure may be used, especially among female patients, to help monitor for risk of worsening fibrosis during methotrexate therapy," the authors write.


Explore further

NASH ID'd by mass spectrometry-based profiling, clinical variables

More information: Abstract/Full Text
Journal information: JAMA Dermatology

Copyright © 2017 HealthDay. All rights reserved.

Citation: Noninvasive test for NASH, fibrosis in patients with psoriasis (2017, August 25) retrieved 19 September 2019 from https://medicalxpress.com/news/2017-08-noninvasive-nash-fibrosis-patients-psoriasis.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
1 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more